These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8900794)

  • 41. Statistical conclusion validity and type IV errors in rehabilitation research.
    Ottenbacher KJ
    Arch Phys Med Rehabil; 1992 Feb; 73(2):121-5. PubMed ID: 1543405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statistical Validation of Surrogate Endpoints: Another Look at the Prentice Criterion and Other Criteria.
    Saraf S; Mathew T; Roy A
    J Biopharm Stat; 2015; 25(6):1234-46. PubMed ID: 25372337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statistical significance versus clinical relevance.
    van Rijn MHC; Bech A; Bouyer J; van den Brand JAJG
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii6-ii12. PubMed ID: 28064161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Misinterpreting p: The discrepancy between p values and the probability the null hypothesis is true, the influence of multiple testing, and implications for the replication crisis.
    Anderson SF
    Psychol Methods; 2020 Oct; 25(5):596-609. PubMed ID: 31829657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bias in error estimation when using cross-validation for model selection.
    Varma S; Simon R
    BMC Bioinformatics; 2006 Feb; 7():91. PubMed ID: 16504092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What is the value of a p value?
    Grunkemeier GL; Wu Y; Furnary AP
    Ann Thorac Surg; 2009 May; 87(5):1337-43. PubMed ID: 19379861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decision qualities of Bayes factor and p value-based hypothesis testing.
    Jeon M; De Boeck P
    Psychol Methods; 2017 Jun; 22(2):340-360. PubMed ID: 28594227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. When being "most likely" is not enough: examining the performance of three uses of the parametric bootstrap in phylogenetics.
    Antezana M
    J Mol Evol; 2003 Feb; 56(2):198-222. PubMed ID: 12574867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Empowering research: statistical power in general practice research.
    Fox N; Mathers N
    Fam Pract; 1997 Aug; 14(4):324-9. PubMed ID: 9283855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A practitioner's guide to developing critical appraisal skills: what is the difference between clinical and statistical significance?
    Brignardello-Petersen R; Carrasco-Labra A; Shah P; Azarpazhooh A
    J Am Dent Assoc; 2013 Jul; 144(7):780-6. PubMed ID: 23813258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Test of association: which one is the most appropriate for my study?
    Gonzalez-Chica DA; Bastos JL; Duquia RP; Bonamigo RR; Martínez-Mesa J
    An Bras Dermatol; 2015; 90(4):523-8. PubMed ID: 26375222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Bayesian decision procedure for testing multiple hypotheses in DNA microarray experiments.
    Gómez-Villegas MA; Salazar I; Sanz L
    Stat Appl Genet Mol Biol; 2014 Feb; 13(1):49-65. PubMed ID: 24317791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Explorations in statistics: power.
    Curran-Everett D
    Adv Physiol Educ; 2010 Jun; 34(2):41-3. PubMed ID: 20522895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An optimal three-stage design for phase II clinical trials.
    Ensign LG; Gehan EA; Kamen DS; Thall PF
    Stat Med; 1994 Sep; 13(17):1727-36. PubMed ID: 7997706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SNOOP:a program for demonstrating the consequences of premature and repeated null hypothesis testing.
    Strube MJ
    Behav Res Methods; 2006 Feb; 38(1):24-7. PubMed ID: 16817510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second-generation p-values: Improved rigor, reproducibility, & transparency in statistical analyses.
    Blume JD; D'Agostino McGowan L; Dupont WD; Greevy RA
    PLoS One; 2018; 13(3):e0188299. PubMed ID: 29565985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Principles: when there should be no difference--how to fail to reject the null hypothesis.
    Lew MJ
    Trends Pharmacol Sci; 2006 May; 27(5):274-8. PubMed ID: 16595154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. To P or Not to P: Backing Bayesian Statistics.
    Buchinsky FJ; Chadha NK
    Otolaryngol Head Neck Surg; 2017 Dec; 157(6):915-918. PubMed ID: 29192853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypothesis Testing in Superiority, Noninferiority, and Equivalence Clinical Trials: Implications in Physical Medicine and Rehabilitation.
    Kumbhare D; Alavinia M; Furlan J
    Am J Phys Med Rehabil; 2019 Mar; 98(3):226-230. PubMed ID: 30138127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reverse-Bayes analysis of two common misinterpretations of significance tests.
    Held L
    Clin Trials; 2013 Apr; 10(2):236-42. PubMed ID: 23329516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.